
14.73 BATS BZX Real-Time Price As of 11:23am ET | ![]() Today’s Change | 3.16 Today|||52-Week Range 18.20 | +134.93% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $1.8B |
CymaBay Therapeutics, Inc. 7575 Gateway Boulevard Newark California 94560 |
Sujal Shah | President, Chief Executive Officer & Director |
Harish Shantharam | Chief Financial Officer |
Charles A. McWherter | President-Research & Development |
Paul T. Quinlan | Secretary & Chief Compliance Officer |
Patrick J. O'Mara | Senior Vice President-Business Development |